529 related articles for article (PubMed ID: 27882487)
41. Effective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexes.
Leus NG; Talman EG; Ramana P; Kowalski PS; Woudenberg-Vrenken TE; Ruiters MH; Molema G; Kamps JA
Int J Pharm; 2014 Jan; 459(1-2):40-50. PubMed ID: 24239833
[TBL] [Abstract][Full Text] [Related]
42. Transfection of brain capillary endothelial cells in primary culture with defined blood-brain barrier properties.
Burkhart A; Thomsen LB; Thomsen MS; Lichota J; Fazakas C; Krizbai I; Moos T
Fluids Barriers CNS; 2015 Aug; 12():19. PubMed ID: 26246240
[TBL] [Abstract][Full Text] [Related]
43. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs.
Stremersch S; Vandenbroucke RE; Van Wonterghem E; Hendrix A; De Smedt SC; Raemdonck K
J Control Release; 2016 Jun; 232():51-61. PubMed ID: 27072025
[TBL] [Abstract][Full Text] [Related]
44. ALIX increases protein content and protective function of iPSC-derived exosomes.
Sun R; Liu Y; Lu M; Ding Q; Wang P; Zhang H; Tian X; Lu P; Meng D; Sun N; Xiang M; Chen S
J Mol Med (Berl); 2019 Jun; 97(6):829-844. PubMed ID: 30944935
[TBL] [Abstract][Full Text] [Related]
45. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
46. [Vascular endothelial growth factor shRNA mediated by pEGFP-H1 vector plasmid effectively inhibits glioma proliferation: an experimental study].
Jiang XB; Zhao HY; Zhou F; Liu RE; Zhang FC; Zhao JS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):547-50. PubMed ID: 15949336
[TBL] [Abstract][Full Text] [Related]
47. Assessment of drug delivery and anticancer potentials of nanoparticles-loaded siRNA targeting STAT3 in lung cancer, in vitro and in vivo.
Das J; Das S; Paul A; Samadder A; Bhattacharyya SS; Khuda-Bukhsh AR
Toxicol Lett; 2014 Mar; 225(3):454-66. PubMed ID: 24440344
[TBL] [Abstract][Full Text] [Related]
48. Treatment of human neuroblastoma cell line SH-SY5Y with HSP27 siRNA tagged-exosomes decreased differentiation rate into mature neurons.
Shokrollahi E; Nourazarian A; Rahbarghazi R; Salimi L; Karbasforush S; Khaksar M; Salarinasab S; Abhari A; Heidarzadeh M
J Cell Physiol; 2019 Nov; 234(11):21005-21013. PubMed ID: 31012118
[TBL] [Abstract][Full Text] [Related]
49. Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping.
Zheng Z; Li Z; Xu C; Guo B; Guo P
J Control Release; 2019 Oct; 311-312():43-49. PubMed ID: 31446085
[TBL] [Abstract][Full Text] [Related]
50. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
[TBL] [Abstract][Full Text] [Related]
51. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of retinal neovascularization by gene transfer of small interfering RNA targeting HIF-1alpha and VEGF.
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
J Cell Physiol; 2009 Jan; 218(1):66-74. PubMed ID: 18767037
[TBL] [Abstract][Full Text] [Related]
53. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
54. [Inhibitory effect of interfering RNA targeting HIF-1alpha and VEGF on retinal neovascularization in the mouse].
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):921-8. PubMed ID: 19176122
[TBL] [Abstract][Full Text] [Related]
55. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation.
Yang Z; Xie J; Zhu J; Kang C; Chiang C; Wang X; Wang X; Kuang T; Chen F; Chen Z; Zhang A; Yu B; Lee RJ; Teng L; Lee LJ
J Control Release; 2016 Dec; 243():160-171. PubMed ID: 27742443
[TBL] [Abstract][Full Text] [Related]
56. VEGF-specific siRNAs modified with 2'-deoxy effectively suppress VEGF expression and inhibit growth of nasopharyngeal carcinoma xenograft in a mouse model.
Chen S; Gao G; Chen W; Lü Q; Tang S; Hua Z; Ye W; Gu D; Wang S; Zhang Y
Sci China C Life Sci; 2008 Feb; 51(2):104-10. PubMed ID: 18239887
[TBL] [Abstract][Full Text] [Related]
57. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
58. Exosomes Derived from Brain Metastatic Breast Cancer Cells Destroy the Blood-Brain Barrier by Carrying lncRNA GS1-600G8.5.
Lu Y; Chen L; Li L; Cao Y
Biomed Res Int; 2020; 2020():7461727. PubMed ID: 32337272
[TBL] [Abstract][Full Text] [Related]
59. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma.
Kim WJ; Christensen LV; Jo S; Yockman JW; Jeong JH; Kim YH; Kim SW
Mol Ther; 2006 Sep; 14(3):343-50. PubMed ID: 16765648
[TBL] [Abstract][Full Text] [Related]
60. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
